Indipendent and Tandem Expression of a Novel Antimicrobial Peptides Plectasin in Escherichia coli

Abstract:

Plectasin, a novel antimicrobial peptide, is isolated from a saprophytic fungus Pseudoplectania nigrella. Plectasin showed potent antibacterial activity in vitro against Gram-positive, especially the Streptococcus pneumoniae and Streptococcus pneumoniae, including strains resistant to conventional antibiotics. In our previous study, plectasin had been expressed at a high yield as a thioredoxin (Trx) – fused protein in Escherichia coli. However, it couldn’t exhibit the antimicrobial activity unless the Trx-tag had been cleaved, which made the producing process be complicated. Concerning that plectasin has no complex post-translational modification and toxicity on E. coli, on the basis of the former works, we further establish the independent and tandem expression system of plectasin in E. coli. In the present study, the coding sequence of plectasin was obtained from pET32a-PLEC with four primers to amplify the independent and tandem plectasin fragments by overlapping PCR-based gene synthesis, and then cloned into pET22b (+) vector. The recombinant protein was expressed successfully in E. coli with IPTG induction. These works might throw light on the production or study of plectasin, and contribute to the development of novel anti-infectious drugs in the future.

• Periodical: Advanced Materials Research (Volume 345)
• Pages: 134-138
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.345.134
• Online since: September 2011
• Authors: Li Hui Lv, Xue Gang Luo, Meng Ni, Xiao Lan Jing, Nan Wang, Yong Jiang, Tong Cun Zhang
• Keywords: Aantimicrobial Peptide, E. coli, Expression, Plectasin

References

[1] P.H. Mygind, R.L. Fischer, K.M. Schnorr, M.T. Hansen, C.P. Sönksen, S. Ludvigsen, et al, Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus, Nature, vol. 437, Oct. 2005, pp.975-980.

DOI: 10.1038/nature04051

[2] K.S. Brinch, A. Sandberg, P. Baudoux, F.V. Bambeke, P.M. Tulkens, N. Frimodt-Møller, et al, Plectasin shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in the Mouse Peritonitis Model, Antimicrob Agents Chemother, vol. 53, Nov. 2009, pp.4801-4808.

DOI: 10.1128/aac.00685-09

[3] S. Hara, H. Mukae, N. Sakamoto, H. Ishimoto, M. Amenomori, H. Fujita, et al, Plectasin has antibacterial activity and no affect on cell viability or IL-8 production, Biochem Biophys Res Commun, vol. 374, Oct. 2008, pp.709-713.

DOI: 10.1016/j.bbrc.2008.07.093

[4] C. Ostergaard, D. Sandvang, N. Frimodt-Møller and H.H. Kristensen, High Cerebrospinal Fluid (CSF) Penetration and Potent Bactericidal Activity in CSF of NZ2114, a Novel Plectasin Variant, during Experimental Pneumococcal Meningitis, Antimicrobial Agents and Chemotherapy, vol. 53, Apr. 2009, pp.1581-1585.

DOI: 10.1128/aac.01202-08

[5] X.L. Jing, X.G. Luo, W.J. Tian, L.H. Lv, Y. Jiang, N. Wang, et al, High-level expression of the antimicrobial peptide plectasin in Escherichia coli, Current Microbiology, Feb. (2010).

DOI: 10.1007/s00284-010-9596-3

[6] M. Gustavsson, J. Lehtio and S. Denman, Stable linker peptides for a cellulose-binding domain-lipase fusion protein expressed in Pichia Pastoris, Protein Engineering, Vol. 14, sep. 2001, pp.711-715.

DOI: 10.1093/protein/14.9.711

[7] C.J. Crasto and J.A. Feng, Linker: A program to gemerate linker sequence for fusion protein, Protein Engineering, Vol. 13, May. 2000, pp.309-312.

DOI: 10.1093/protein/13.5.309

[8] R. Trinh, B. Gurxani, S.L. Morrison and M. Seyzadeh, Optimization of condon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression, Mol Immunol, Vol. 40, Jan. 2004, pp.717-722.

DOI: 10.1016/j.molimm.2003.08.006

[9] H. Schagger, Tricine-SDS-PAGE, Nature Protocols, Vol 1, May. 2006, pp.16-22.

[10] E.L. Snary, L.A. Kelly, H.C. Davison, C.J. Teale and M. Wooldridge, Antimicrobial resistance: a microbial risk assessment perspective, J Antimicrob Chemother, vol. 53, Jun. 2004, pp.906-917.

DOI: 10.1093/jac/dkh182

[11] D. Greenwood, Resistance to antimicrobial agents: a personal view, J Med Microbiol, vol. 47, Sep. 1998, pp.751-755.

[12] H. Jenssen, P. Hamill and R.E. Hancock, Peptide antimicrobial agents, Clin Microbiol Rev, vol. 19, Jul. 2006, pp.491-511.

DOI: 10.1128/cmr.00056-05

[13] A.L. Demain and P. Vaishnav, Production of recombinant proteins by microbes and higher organisms, Biotechnol Adv, vol. 27, May-Jun. 2009, pp.297-306.

DOI: 10.1016/j.biotechadv.2009.01.008